Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Lam, Thomas B L ^a   Omar, Muhammad Imran ^a   Fisher, Euan ^a   Gillies, Katie ^b   Maclennan, Sara ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; ANTIINFECTIVE AGENT; METAL OXIDE; MINOCYCLINE; NITROFURAL; POLITEF; POLYVINYLCHLORIDE; RIFAMPICIN; SILVER ALLOY HYDROGEL; SILVER OXIDE; UNCLASSIFIED DRUG; SILVER; URINARY TRACT ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIURIA; BURNING SENSATION; CATHETER REMOVAL; CLINICAL EFFECTIVENESS; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INFECTION RISK; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SHORT COURSE THERAPY; SLEEP DISORDER; SYSTEMATIC REVIEW; TREATMENT DURATION; URETHRAL CATHETERIZATION; URETHRITIS; URINARY TRACT INFECTION; ADVERSE EFFECTS; BLADDER CATHETERIZATION; CATHETER-RELATED INFECTIONS; DEVICES; INDWELLING CATHETER; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); URINARY TRACT INFECTIONS; URINATION DISORDERS;

ADULT; ALLOYS; ANTI-INFECTIVE AGENTS, URINARY; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; HUMANS; MINOCYCLINE; NITROFURAZONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIFAMPIN; SILVER; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; URINATION DISORDERS;

EID: 84942751971     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004013.pub4     Document Type: Review

References (107)

1. Al Habdan I, Sadat-Ali M, Corea JR, Al Othman A, Kamal BA, Shriyan DS. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery 2003;88(3):152-4. [: 17332]
2. Chene G, Boulard G, Gachie JP. A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie 1990;31(8):499-501.
3. Darouiche RO, Smith JA, Hanna H, Dhabuwala CB, Steiner MS, Babaian RJ, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology 1999;54(6):976-87.
4. Goodwin MI, Chester JF. Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three-way catheters. Annals of the Royal College of Surgeons of England 1990;72(2):125-7.
5. Johnson JR, Roberts PL, Olsen RJ, Moyer KA, Stamm WE. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases 1990;162:1145-50.
6. Kalambheti K. Siliconized Foley catheters. American Journal of Surgery 1965;110(6):935-6.
7. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Archives of Internal Medicine 2000;160(2):3294-8.
8. Lee SJ, Kim SW, Cho YH, Shin WS, Lee SE, Kim CS, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. International Journal of Antimicrobial Agents 2004;24(Suppl 1):S65-9. [: 20993]
9. Liedberg T, Lundeberg PE. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. European Urology 1990;17(3):236-40.
10. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. British Journal of Urology 1990;65(4):379-81.
11. Liedberg H, Lundeberg T. Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver-coated catheters or Bard hydrogel-coated catheters (Abstract number 769). Journal of Urology 1993;149:405A. [: 21457]
12. Lundeberg T. Prevention of catheter-associated urinary tract infections by use of silver impregnated catheters. Lancet 1986;2(8514):1031.
13. Maki DG, Holcomb RG. A report on the randomized, controlled clinical trial of the nitrofurazone-impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation.
14. Maki DG, Knasinski V, Halvorson K, Tambyah PA. A novel silver-hydrogel-impregnated indwelling urinary catheter reduces CAUTIs: A prospective double-blind trial. Infection Control and Hospital Epidemiology 1998;1992(19):682.
15. Nacey JN, Tulloch AGS, Ferguson AS. Catheter-induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology 1984;57:325-8.
16. Nickel JC, Feero P, Costerton W, Wilson E. Incidence and importance of bacteriuria in postoperative, short-term urinary catheterization. Canadian Journal of Surgery 1989;32(2):131-2.
17. Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140-6736(12)61380-4]
18. Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technology Assessment 2012;16(47):1-197.
19. Schumm K, N'Dow J, Norrie J, CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18-21 May; St Louis. St Louis (MO), 2008.
20. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine 1995;98(4):349-56.
21. Stensballe J, Tvede M, Looms D, Lippert FK, Dahl B, Tonnesen E, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine 2007;147(5):285-93. [: SR-INCONT23739]
22. Stenzelius K, Persson S, Olsson UB, Stjarneblad M. Noble metal alloy-coated latex versus silicone Foley catheter in short-term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology 2011;45(4):258-64.
23. Takeuchi H, Hida S, Yoshida O, Ueda T. Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections. Hinyokika Kiyo 1993;39(3):293-8.
24. Talja M, Korpela A, Jarvi K. Comparison of urethral reaction to full silicone hydrogel-coated and siliconised latex catheters. British Journal of Urology 1990;66(6):652-7.
25. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infection. Journal of Hospital Infection 2000;45(2):117-24.
26. Tidd MJ, Gow JG, Pennington JH, Shelton J, Scott MR. Comparison of hydrophilic polymer-coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology 1976;48(4):285-91.
27. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. European Urology 1999;36(3):240-6.
28. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. European Urology 1999;36(3):240-6.
29. Andersson H. A double-blind randomised comparison of the effect and tolerance of varidase versus saline when instilled in the urinary bladder in patients with catheter problems. Journal of International Medical Research 1986;14(2):91-4.
30. Bach D, Hesse A, Prange CH. Prevention of incrustations and urinary tract infections during transurethral continuous catheterization [German]. Therapiewoche Urologie Nephrologie 1990;2(1):25-32.
31. Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999;54(6):982-7.
32. Britt MR, Garibaldi RA, Miller WA, Herbertson RM, Burke JP. Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrobial Agents and Chemotherapy 1977;11(2):240-3.
33. Cleland V, Cox F, Berggren H, MacInnis MR. Prevention of bacteriuria in female patients with indwelling catheters. Nursing Research 1971;20(4):309-18.
34. Day RA, Moore KN, Albers MK. A pilot study comparing two methods of intermittent catheterization: limitations and challenges. Urologic Nursing 2003;23(2):143-7, 158.
35. Domurath B, Kutzenberger J, Kurze I, Knoth HS. Clinical evaluation of a newly developed catheter (SpeediCath Compact Male) in men with spinal cord injury: residual urine and user evaluation. Spinal Cord 2011;49(7):817-21.
36. Erickson BA, Navai N, Patil M, Chang A, Gonzalez CM. A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. Journal of Urology 2008;179(1):203-6.
37. Ghoreishi J. Indwelling urinary catheters in cesarean delivery. International Journal of Gynecology and Obstetrics 2003;83(3):267-70.
38. Grocela JA, Jura YH. Top-vented urinary drainage catheters cause fewer epithelial and vascular changes in the bladder mucosa compared to conventional catheters and may reduce susceptibility to urinary tract infections. Current Urology 2010;4(3):136-41.
39. Hakvoort R, Roovers J. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology 2012;119(1):113-4.
40. Hakvoort R, Roovers J. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology 2012;119(1):115-6.
41. Hakvoort RA, Thijs SD, Bouwmeester FW, Broekman AM, Ruhe IM, Vernooij MM, et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology 2011;118(9):1055-60.
42. Hart AJ, Fowler JW. Incidence of urethral stricture after transurethral resection of prostate. Effects of urinary infection, urethral flora, and catheter material and size. Urology 1981;18(6):588-91. [: SR-INCONT26236]
43. Lee J, Hernandez J. Silver/hydrogel-coated catheters to reduce incidence of nosocomial urinary tract infection. American Journal of Infection Control 1996;224(2):117.
44. Leone M, Garnier F, Antonini F, Bimar MC, Albanese J, Martin C. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Medicine 2003;29(3):410-3.
45. Leone M, Garnier F, Antonini F, Bimar MC, Albanese J, Martin C. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Medicine 2003;29(4):551-4.
46. Leone M, Perrin AS, Granier I, Visintini P, Blasco V, Antonini F, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Medicine 2007;33(4):726-9.
47. Leriche A, Charvier K, Bonniaud V, Peyrat L, N'Guyen P, Soler JM, et al. Comparative study of the acceptability of the SpeediCath Set and Actreen set catheterization sets in patients performing self-catheterization [French]. Progres en Urologie 2006;16(3):347-51.
48. Litherland AT, Schiotz HA. Patient-perceived discomfort with two coated urinary catheters. British Journal of Nursing 2007;16(5):284-7.
49. Nakada J, Kawahara M, Onodera S, Oishi Y. Clinical study of silver lubricath Foley catheter. Hinyokika Kiyo 1996;42:433-8.
50. Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex Foley catheters on urinary tract infections in burn patients. Infection Control and Hospital Epidemiology 2002;23(4):217-8.
51. Pachler J, Fromodt-Moller C. Pre-lubricated hydrophilic PVC urethral catheters compared to non-hydrophilic PVC catheters. Neurology and Urodynamics 1998;14(4):325.
52. Ratahi E, Lynskey T. Preoperative urethral catheterisation in patients undergoing total hip and knee arthroplasty. A randomized controlled trial (Abstract). Journal of Bone and Joint Surgery - British Volume 2005;87-B(Suppl 1):21.
53. Rigini N, Evron S, Sadan O, Szmuk P, Ezri T. Intermittent versus continuous bladder catheterization and labor epidural (Abstract). Anesthesiology 2006;105:A907.
54. Sallami S, Mouine Y, Rhouma SB, Cherif K, Dahmani A, Horchani A. Clean intermittent catheterization following urethral stricture surgery using a low friction catheter versus conventional plastic catheter: a prospective, randomized trial. UroToday International Journal 2011;4:1.
55. Schaeffer AJ, Story KO, Johnson SM. Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. Journal of Urology 1988;139(1):69-73.
56. Shafik A. The electrified catheter: role in sterilizing urine and decreasing bacteriuria. World Journal of Urology 1993;11(3):183-5.
57. Sun JL, Lu YP, Huang B, Tu HL, Zhou XY, Chen QM, et al. Effect of a novel analgesic disposable urinary catheter in prevention of restlessness caused by catheter-related bladder discomfort in general anesthesia patients in recovery period [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2008;88(25):1750-2.
58. Teare EL, Lewi H, Peacock A, Marshall S, Norton M, Robertson MB, et al.'Silverline', a device for the prevention of nosocomial bacteriuria?. Journal of Hospital Infection 1992;21(2):154-6.
59. Witjes A, Marberger M, Del Popolo G, Jonsson O, Kaps H, Chapple CR, et al. Is a PVC-free catheter as well tolerated as a PVC catheter? A randomised multi-centre double blind study in experienced users of clean intermittent catheterisation (Abstract number 100). Neurourology and Urodynamics 2008;27(7):688-9.
60. NCT00482547, Rupp M, Dulin J. Study of a urethral catheter coated with eluting silver salts. http://clinicaltrials.gov/show/NCT00482547 2007.
61. NCT01681511, Kline SE. A randomized trial for the safety and effectiveness of a novel antimicrobial-coated Foley catheter attached to an antimicrobial anti-reflux device for reduction of catheter-associated urinary tract infection. http://clinicaltrials.gov/show/NCT01681511 2012.
62. NCT02198833, Darouiche R, Fisher K. Clinical study to assess the efficacy of a novel micro-patterned Foley catheter to reduce catheter-associated urinary tract infection among spinal cord injury patients. http://clinicaltrials.gov/show/NCT02198833 2014.
63. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. Journal of Urology 1984;132(3):494-8.
64. Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee. Guideline for Prevention of Catheter-Associated Urinary Tract Infections. www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf (accessed July 2011).
65. Drekonja DM, Kuskowski MA, Wilt TJ, Johnson JR. Antimicrobial urinary catheters: a systematic review. Expert Review of Medical Devices 2008;5(4):495-506.
66. Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals-overview of the results. Journal of Hospital Infection 1996;32(3):175-90.
67. Franken A, van den Bosch EEM, Crespo-Biel O, Loontjens JA, Dias AA. Anti-microbial coatings for urological applications. European Cells and Materials 2007;14 Suppl 3:130.
68. Gargon E, Williamson PR, Altman DG, Blazeby JM, Clarke M. The COMET Initiative database: progress and activities from 2011 to 2013. Trials 2014;10(15):279. [doi: 10.1186/1745-6215-15-279]
69. Garibaldi RA, Mooney BR, Epstein BJ. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infection Control 1982;3(6):466-70.
70. Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, et al.Silver-coated megaendoprostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials 2004;25(24):5547-56.
71. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Guideline for prevention of catheter-associated urinary tract infections 2009. Infection Control and Hospital Epidemiology 2010;31(4):319-26.
72. Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004011.pub3;: CD004011]
73. Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001;61(3):353-64.
74. Guyatt 2011Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articlesin the Journal of Clinical Epidemiology. Journal of ClinicalEpidemiology 2011;64(4):380-2.
75. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, et al. Nosocomial infections in US hospitals, 1975-1976: estimated frequency by selected characteristics of patients. American Journal of Medicine 1981;70(4):947-59.
76. Hartstein AI, Garber SB, Ward TT, Jones SR, Morthland VH. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infection Control 1981;2(5):380-6.
77. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
78. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
79. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Annals of Internal Medicine 2006;144(2):116-26.
80. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. Journal of Infectious Diseases 1983;148(1):57-62.
81. Lusardi G, Lipp A, Shaw C. Antibiotic prophylaxis for short-term catheter bladder drainage in adults. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD005428.pub2;: CD005428]
82. Niel-Weise BS, Arend SM, van den Broek PJ. Is there evidence for recommending silver-coated urinary catheters in guidelines?. Journal of Hospital Infection 2002;52(2):81-7.
83. Niël-Weise BS, van den Broek PJ. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005428;: CD005428]
84. Niël-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004203.pub2;: CD004203]
85. Omar MI, Lam T, MacLennan. Critical outcomes in a Cochrane Systematic Review: patients' perspective. Cochrane Database Syst Rev Suppl 1-212. 2013:2. [: DOI:10.1002/14651858.CD201300]
86. Parker D, Callan L, Harwood J, Thompson DL, Wilde M, Gray M. Nursing interventions to reduce the risk of catheter-associated urinary tract infection. Part 1: Catheter selection. Journal of Wound, Ostomy and Continence Nursing 2009;36(1):23-34.
87. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. Journal of Hospital Infection 2005;60(1):1-7.
88. Phipps S, Lim YN, McClinton S, Barry C, Rane A, N'Dow JMO. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD004374.pub2;: CD004374]
89. Plowman R, Graves N, Esquive J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. Journal of Hospital Infection 2001;48(1):38-42.
90. Pomfret I. Catheter care in the community. Nursing Standard 2000;14(27):46-53.
91. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al.epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 2007;65 Suppl 1:S1-S64.
92. Thomson Reuters. Reference Manager Professional Edition. 12. New York: Thomson Reuters, 2012.
93. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
94. Robinson J. Urethral catheter selection. Nursing Standard 2001;15(25):39-42.
95. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta-analysis. American Journal of Medicine 1998;105:236-41. [MEDLINE: 99086386]
96. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Archives of Internal Medicine 2000;160(17):2670-5.
97. Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Critical Care Medicine 2010;38(8 Suppl):S373-9.
98. Smyth ET, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. Journal of Hospital Infection 2008;69(3):230-48.
99. Stamm WE. Urinary tract infection. In: Bennett JV, Brachmand PS editor(s). Hospital Infections. 4th Edition. Philadelphia: Lippincott-Raven, 1998:477-85.
100. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infection Control and Hospital Epidemiology 2002;23(1):27-31.
101. Turck M, Stamm W. Nosocomial infection of the urinary tract. American Journal of Medicine 1981;70(3):651-4.
102. Ware JE, Snow KK, Kosinski M, Gandek B. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [MEDLINE: 92278120]
103. Weinstein JW, Mazon D, Pantelick E, Reagan-Cirincione P, Dembry LM, Hierholzer WJ Jr. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infection Control and Hospital Epidemiology 1999;20(8):543-8.
104. Willson M, Wilde M, Webb ML, Thompson D, Parker D, Harwood J, et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection: part 2: staff education, monitoring, and care techniques. Journal of Wound, Ostomy, and Continence Nursing 2009;36(2):137-54.
105. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361-70.
106. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD004013.pub2]
107. Schumm K, Lam TBL. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD004013.pub3;: CD004013]